GCM
Gladius Capital Management’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $218K | Sell |
1,173
-4,294
| -79% | -$797K | 0.08% | 25 |
|
2025
Q1 | $1.15M | Sell |
5,467
-3,590
| -40% | -$752K | 0.3% | 21 |
|
2024
Q4 | $1.61M | Buy |
9,057
+2,667
| +42% | +$474K | 0.17% | 24 |
|
2024
Q3 | $1.26M | Buy |
6,390
+2,149
| +51% | +$424K | 0.15% | 29 |
|
2024
Q2 | $727K | Buy |
4,241
+1,798
| +74% | +$308K | 0.09% | 44 |
|
2024
Q1 | $445K | Buy |
+2,443
| New | +$445K | 0.15% | 53 |
|
2023
Q4 | – | Sell |
-8,844
| Closed | -$1.32M | – | 228 |
|
2023
Q3 | $1.32M | Buy |
8,844
+3,455
| +64% | +$515K | 0.06% | 32 |
|
2023
Q2 | $726K | Buy |
5,389
+3,632
| +207% | +$489K | 0.04% | 24 |
|
2023
Q1 | $280K | Sell |
1,757
-953
| -35% | -$152K | 0.02% | 60 |
|
2022
Q4 | $438K | Sell |
2,710
-6,357
| -70% | -$1.03M | 0.03% | 56 |
|
2022
Q3 | $1.22M | Buy |
9,067
+7,374
| +436% | +$990K | 0.05% | 44 |
|
2022
Q2 | $260K | Sell |
1,693
-5,325
| -76% | -$818K | 0.01% | 90 |
|
2022
Q1 | $1.14M | Buy |
7,018
+5,280
| +304% | +$856K | 0.08% | 23 |
|
2021
Q4 | $236K | Buy |
1,738
+1,001
| +136% | +$136K | 0.02% | 84 |
|
2021
Q3 | $80K | Buy |
737
+302
| +69% | +$32.8K | 0.01% | 19 |
|
2021
Q2 | $49K | Buy |
+435
| New | +$49K | ﹤0.01% | 23 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 38 |
|
2020
Q4 | – | Sell |
-3,104
| Closed | -$272K | – | 40 |
|
2020
Q3 | $272K | Buy |
+3,104
| New | +$272K | 0.03% | 43 |
|
2020
Q1 | – | Sell |
-426
| Closed | -$38K | – | 44 |
|
2019
Q4 | $38K | Sell |
426
-5,485
| -93% | -$489K | ﹤0.01% | 35 |
|
2019
Q3 | $448K | Sell |
5,911
-349
| -6% | -$26.5K | 0.02% | 50 |
|
2019
Q2 | $460K | Sell |
6,260
-19,882
| -76% | -$1.46M | 0.03% | 39 |
|
2019
Q1 | $2.11M | Sell |
26,142
-1,294
| -5% | -$104K | 0.12% | 35 |
|
2018
Q4 | $2.53M | Buy |
27,436
+24,291
| +772% | +$2.24M | 0.12% | 41 |
|
2018
Q3 | $297K | Sell |
3,145
-4,567
| -59% | -$431K | 0.03% | 29 |
|
2018
Q2 | $715 | Buy |
+7,712
| New | +$715 | 0.07% | 28 |
|